Experiment: 2KG4

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.45mM [U-99% 15N] gadd45a-7, 20mM sodium phosphate-8, 100mM potassium chloride-9, 2mM DTT-10, 2mM EDTA-11, 0.03% sodium azide-12	93% H2O/7% D2O	0.27	7.4	ambient	298
2	2D 1H-13C HMQC-aliphatic	0.45mM [U-99% 13C; U-99% 15N] gadd45a-1, 20mM sodium phosphate-2, 100mM potassium chloride-3, 2mM DTT-4, 2mM EDTA-5, 0.03% sodium azide-6	93% H2O/7% D2O	0.27	7.4	ambient	298
3	3D HNCO	0.45mM [U-99% 13C; U-99% 15N] gadd45a-1, 20mM sodium phosphate-2, 100mM potassium chloride-3, 2mM DTT-4, 2mM EDTA-5, 0.03% sodium azide-6	93% H2O/7% D2O	0.27	7.4	ambient	298
4	3D HNCA	0.45mM [U-99% 13C; U-99% 15N] gadd45a-1, 20mM sodium phosphate-2, 100mM potassium chloride-3, 2mM DTT-4, 2mM EDTA-5, 0.03% sodium azide-6	93% H2O/7% D2O	0.27	7.4	ambient	298
5	3D HNCACB	0.45mM [U-99% 13C; U-99% 15N] gadd45a-1, 20mM sodium phosphate-2, 100mM potassium chloride-3, 2mM DTT-4, 2mM EDTA-5, 0.03% sodium azide-6	93% H2O/7% D2O	0.27	7.4	ambient	298
6	3D CBCA(CO)NH	0.45mM [U-99% 13C; U-99% 15N] gadd45a-1, 20mM sodium phosphate-2, 100mM potassium chloride-3, 2mM DTT-4, 2mM EDTA-5, 0.03% sodium azide-6	93% H2O/7% D2O	0.27	7.4	ambient	298
7	3D HN(CO)CA	0.45mM [U-99% 13C; U-99% 15N] gadd45a-1, 20mM sodium phosphate-2, 100mM potassium chloride-3, 2mM DTT-4, 2mM EDTA-5, 0.03% sodium azide-6	93% H2O/7% D2O	0.27	7.4	ambient	298
8	3D HNHA	0.45mM [U-99% 15N] gadd45a-7, 20mM sodium phosphate-8, 100mM potassium chloride-9, 2mM DTT-10, 2mM EDTA-11, 0.03% sodium azide-12	93% H2O/7% D2O	0.27	7.4	ambient	298
9	3D 1H-15N NOESY	0.45mM [U-99% 15N] gadd45a-7, 20mM sodium phosphate-8, 100mM potassium chloride-9, 2mM DTT-10, 2mM EDTA-11, 0.03% sodium azide-12	93% H2O/7% D2O	0.27	7.4	ambient	298
10	2D 1H-1H NOESY	0.195mM gadd45a-13, 20mM sodium phosphate-14, 100mM potassium chloride-15, 2mM DTT-16, 2mM EDTA-17, 0.03% sodium azide-18	100% D2O	0.27	7.4	ambient	298
11	2D 1H-15N HSQC	0.45mM [U-15N]-Leu gadd45a-19, 20mM sodium phosphate-20, 100mM potassium chloride-21, 2mM DTT-22, 2mM EDTA-23, 0.03% sodium azide-24	93% H2O/7% D2O	0.27	7.4	ambient	298
12	2D 1H-15N HSQC	0.45mM [U-15N]-Val gadd45a-25, 20mM sodium phosphate-26, 100mM potassium chloride-27, 2mM DTT-28, 2mM EDTA-29, 0.03% sodium azide-30	93% H2O/7% D2O	0.27	7.4	ambient	298
13	2D 1H-15N HSQC	0.45mM [U-15N]-Ile gadd45a-31, 20mM sodium phosphate-32, 100mM potassium chloride-33, 2mM DTT-34, 2mM EDTA-35, 0.03% sodium azide-36	93% H2O/7% D2O	0.27	7.4	ambient	298
14	2D 1H-15N HSQC	0.45mM [U-15N]-Phe/Tyr gadd45a-37, 20mM sodium phosphate-38, 100mM potassium chloride-39, 2mM DTT-40, 2mM EDTA-41, 0.03% sodium azide-42	93% H2O/7% D2O	0.27	7.4	ambient	298
15	2D 1H-13C HMQC-aromatic	0.45mM [U-99% 13C; U-99% 15N] gadd45a-1, 20mM sodium phosphate-2, 100mM potassium chloride-3, 2mM DTT-4, 2mM EDTA-5, 0.03% sodium azide-6	93% H2O/7% D2O	0.27	7.4	ambient	298
16	4D 1H-15N 1H-13C NOESY	0.45mM [U-99% 13C; U-99% 15N] gadd45a-1, 20mM sodium phosphate-2, 100mM potassium chloride-3, 2mM DTT-4, 2mM EDTA-5, 0.03% sodium azide-6	93% H2O/7% D2O	0.27	7.4	ambient	298
17	2D 1H-15N HSQC-TROSY	0.45mM [U-99% 15N] gadd45a-7, 20mM sodium phosphate-8, 100mM potassium chloride-9, 2mM DTT-10, 2mM EDTA-11, 0.03% sodium azide-12	93% H2O/7% D2O	0.27	7.4	ambient	298
18	2D 1H-15N HSQC-TROSY	0.45mM [U-99% 15N] gadd45a-43, 20mM sodium phosphate-44, 100mM potassium chloride-45, 2mM DTT-46, 2mM EDTA-47, 0.03% sodium azide-48, 10 mg/mL Pf1 phage-49	93% H2O/7% D2O	0.27	7.4	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Bruker	AVANCE II	800
3	Bruker	AVANCE II	900

NMR Refinement
Method	Details	Software
molecular dynamics	AMBER 9 explicit water using Gibbs-Boltzman method	NMRPipe

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe	1.02	Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	collection	XwinNMR	3.5	Bruker Biospin
3	processing	NMRDraw	2.3	Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
4	structure solution	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
5	refinement	Amber	9	Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, ... and Kollm
6	collection	TopSpin	2.1	Bruker Biospin
7	data analysis	TopSpin	2.1	Bruker Biospin

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.